1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
3 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | -40.31K | - |
| Net profit | -3.38M | 37.14% |
| EBITDA | -3.13M | 46.07% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €11.07M |
Number of shares | 11.03M |
52-week high/low | €1.46 - €0.40 |
| Dividends | No |
Beta | 0.24 |
P/E ratio | -1.22 |
PEG ratio | -0.02 |
P/B ratio | -1.11 |
P/S ratio | 0.00 |
Company profile
| Name | BrainStorm Cell Therapeutics Aktie |
| CEO | Chaim Lebovits |
| Employees | 19 |
Discover assets
Shareholders of BrainStorm Cell Therapeutics Aktie also invest in the following assets
